Structure-guided design of a dual-antigen mRNA vaccine conferring broad protection against Henipaviruses

Henipaviruses (HNVs), including Nipah virus (NiV) and Hendra virus (HeV), are zoonotic paramyxoviruses with high case fatality rates and pandemic potential. Despite their threat, no licensed vaccines are currently available for human use. Here, we present a structure-guided mRNA vaccine strategy that overcomes key challenges in antigen stability, fusogenicity, and cross-protective efficacy. Using rationally engineered NiV F glycoproteins stabilized in the prefusion conformation, we identify a lead candidate (F-205) that abolishes syncytium formation and elicits high prefusion-specific antibody titers. Through systematic combinatorial screening, we determine that co-delivery of F-205 (NiV-M) and G (NiV-B) antigens via mRNA–lipid nanoparticles induces potent neutralizing and cellular immune responses. In stringent golden hamster challenge models, this vaccine confers complete survival against lethal NiV-M, NiV-B and HeV challenge, with viral RNA undetectable in lung, spleen and brain after NiV challenge and significantly reduced viral burden after HeV challenge. We also introduce surrogate assays to assess F conformation and fusion activity under standard biosafety conditions, enabling iterative antigen optimization without live-virus handling. This study defines a broadly protective, mechanistically informed vaccine platform for HNVs and provides a generalizable framework for rational design of mRNA vaccines targeting class I fusion viruses.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-11-19
DOI
https://doi.org/10.1038/s41467-026-79459-9
Primary Topic
Virology and Viral Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Structure-guided design of a dual-antigen mRNA vaccine conferring broad protection against Henipaviruses

Jinzhong Lin, Ge Gao, Chao Shan, Yanfeng Yao et al.
3 links
Nature Communications
Virology and Viral Diseases
article

Structure-guided design of a dual-antigen mRNA vaccine conferring broad protection against Henipaviruses

Jinzhong Lin, Ge Gao, Chao Shan, Yanfeng Yao, Binhe Du, Zhiming Yuan, Miaoyu Chen, Shuqi Xiao, Mingqing Lu, Ye Li, Yun Peng, Wei Huang, Hang Liu, Hao Gu, Jing Lu
article en

Abstract

Henipaviruses (HNVs), including Nipah virus (NiV) and Hendra virus (HeV), are zoonotic paramyxoviruses with high case fatality rates and pandemic potential. Despite their threat, no licensed vaccines are currently available for human use. Here, we present a structure-guided mRNA vaccine strategy that overcomes key challenges in antigen stability, fusogenicity, and cross-protective efficacy. Using rationally engineered NiV F glycoproteins stabilized in the prefusion conformation, we identify a lead candidate (F-205) that abolishes syncytium formation and elicits high prefusion-specific antibody titers. Through systematic combinatorial screening, we determine that co-delivery of F-205 (NiV-M) and G (NiV-B) antigens via mRNA–lipid nanoparticles induces potent neutralizing and cellular immune responses. In stringent golden hamster challenge models, this vaccine confers complete survival against lethal NiV-M, NiV-B and HeV challenge, with viral RNA undetectable in lung, spleen and brain after NiV challenge and significantly reduced viral burden after HeV challenge. We also introduce surrogate assays to assess F conformation and fusion activity under standard biosafety conditions, enabling iterative antigen optimization without live-virus handling. This study defines a broadly protective, mechanistically informed vaccine platform for HNVs and provides a generalizable framework for rational design of mRNA vaccines targeting class I fusion viruses.

Nature Communications
Shanghai Medical College of Fudan University (CN), Chinese Academy of Sciences (CN), Fudan University (CN), Wuhan Institute of Virology (CN), Zhongshan Hospital (CN), State Key Laboratory of Virology (CN)
National Natural Science Foundation of China, Chinese Academy of Sciences, Fudan University, Shanghai Municipal Education Commission, Science and Technology Commission of Shanghai Municipality, National Key Research and Development Program of China
Good health and well-being
Virology and Viral Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon